Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)
Public ClinicalTrials.gov record NCT02625610. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Open-label, Multicenter Trial of Maintenance Therapy With Avelumab (MSB0010718C) Versus Continuation of First-line Chemotherapy in Subjects With Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro-esophageal Junction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to demonstrate superiority of treatment with avelumab versus continuation of first-line chemotherapy.
Study identification
- NCT ID
- NCT02625610
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 499 participants
Conditions and interventions
Interventions
- Avelumab Drug
- Oxaliplatin Drug
- 5-Fluorouracil Drug
- Leucovorin Drug
- Capecitabine Drug
- Best supportive care Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 24, 2015 (Actual)
- Primary completion
- Sep 13, 2019 (Actual)
- Completion
- Jun 3, 2021 (Actual)
- Last update posted
- Jun 9, 2022
2015 – 2021
United States locations
- U.S. sites
- 35
- U.S. states
- 17
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Blood & Cancer Center | Bakersfield | California | 93309 | — |
| Virginia Crosson Cancer Center | Fullerton | California | 92835 | — |
| UCLA Medical Center | Los Angeles | California | 90095 | — |
| Desert Hematology Oncology Medical Group, Inc. | Rancho Mirage | California | 92262 | — |
| Sansum Clinic | Santa Barbara | California | 93105 | — |
| Trio - Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Norwalk Hospital | Norwalk | Connecticut | 6856 | — |
| UF Health Cancer Center Orlando | Orlando | Florida | 32806 | — |
| Memorial West Cancer Institute | Pembroke Pines | Florida | 33028 | — |
| University of South Florida - Parent | Tampa | Florida | 33606 | — |
| Oncology Specialists, S.C. | Park Ridge | Illinois | 60068 | — |
| Franciscan St. Francis Health Cancer Center | Indianapolis | Indiana | 46237 | — |
| Cedar Rapids Oncology Project | Cedar Rapids | Iowa | 52403 | — |
| Cotton-O'Neil Clinical Research Center, Hematology and Oncology | Topeka | Kansas | 66604 | — |
| University of Kansas Medical Center Research Institute, Inc. | Westwood | Kansas | 66205 | — |
| Virginia Piper Cancer Institute | Minneapolis | Minnesota | 55407 | — |
| Nevada Cancer Research Foundation | Las Vegas | Nevada | 89106 | — |
| Mount Sinai - PRIME | Jamaica | New York | 11432 | — |
| Clinical Research Alliance, Inc | New York | New York | 10021 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| UC Health Clinical Trials Office | Cincinnati | Ohio | 45206 | — |
| TriHealth Hatton Institute | Cincinnati | Ohio | 45220 | — |
| Mid Ohio Oncology Hematology, DBA The Mark H. Zangmeister Center | Columbus | Ohio | 43219 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| St. Luke's Hospital | Bethlehem | Pennsylvania | 18015 | — |
| Thomas Jefferson University Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Rhode Island Hospital | Providence | Rhode Island | 02903 | — |
| Greenville Hospital System University Medical Center (ITOR) | Greenville | South Carolina | 29605 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-9179 | — |
| Oncology Consultants, P.A. | Houston | Texas | 77024 | — |
| University of Texas Health Science Center at San Antonio | San Antonio | Texas | 78229 | — |
| Baylor Scott & White Health | Temple | Texas | 76508 | — |
| University of Washington - Seattle Cancer Care Alliance | East Seattle | Washington | 98109 | — |
| Northwest Medical Specialties, PLLC | Tacoma | Washington | 98405 | — |
| Wenatchee Valley Hospital & Clinics | Wenatchee | Washington | 98801 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 165 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02625610, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 9, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02625610 live on ClinicalTrials.gov.